title: Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant.
authors.affiliation: Transplantation Service, Baylor University Medical Center, Dallas, Texas 75246.
authors.forename: N P
authors.initials: NP
authors.lastname: Mora
authors.forename: G
authors.initials: G
authors.lastname: Klintmalm
authors.forename: H
authors.initials: H
authors.lastname: Solomon
authors.forename: R M
authors.initials: RM
authors.lastname: Goldstein
authors.forename: T A
authors.initials: TA
authors.lastname: Gonwa
authors.forename: B S
authors.initials: BS
authors.lastname: Husberg
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D000666:Amphotericin B; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine